Zimmer Biomet Shoulder Arthroplasty PMCF Study
← catalyst calendarNCT06920459 · readout ≤ 1,046 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
50estimated
Sites
2
Countries
Germany, Netherlands
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-04-29 | actual | When the study began enrolling |
| Primary completion | Jun 2029 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2037 | estimated | The whole study's end, after follow-up |
| First posted | 2025-04-09 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-08 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Shoulder Fractures
- Shoulder Arthritis Osteoarthritis
- Shoulder Injury
- Shoulder Pain
- Degenerative Joint Disease
- Arthritis Shoulder
Intervention
- Device: Alliance™ Glenoid
Primary outcome
what the primary-completion date above is the date OFAmerican Shoulder and Elbow Surgeons (ASES)
measured 2 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed